Luo Jiansong, Busillo John M, Stumm Ralf, Benovic Jeffrey L
Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania (J.L., J.M.B., J.L.B.); and Institute of Pharmacology and Toxicology, University Hospital, Friedrich-Schiller University, Jena, Germany (R.S.).
Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania (J.L., J.M.B., J.L.B.); and Institute of Pharmacology and Toxicology, University Hospital, Friedrich-Schiller University, Jena, Germany (R.S.)
Mol Pharmacol. 2017 Jun;91(6):554-566. doi: 10.1124/mol.116.106468. Epub 2017 Mar 22.
Phosphorylation of G protein-coupled receptors (GPCRs) is a key event for cell signaling and regulation of receptor function. Previously, using tandem mass spectrometry, we identified two phosphorylation sites at the distal C-terminal tail of the chemokine receptor CXCR4, but were unable to determine which specific residues were phosphorylated. Here, we demonstrate that serines (Ser) 346 and/or 347 (Ser-346/7) of CXCR4 are phosphorylated upon stimulation with the agonist CXCL12 as well as a CXCR4 pepducin, ATI-2341. ATI-2341, a G heterotrimer-biased CXCR4 agonist, induced more robust phosphorylation of Ser-346/7 compared with CXCL12. Knockdown of G protein-coupled receptor kinase (GRK) 2, GRK3, or GRK6 reduced CXCL12-induced phosphorylation of Ser-346/7 with GRK3 knockdown having the strongest effect, while inhibition of the conventional protein kinase C (PKC) isoforms, particularly PKC, reduced phosphorylation of Ser-346/7 induced by either CXCL12 or ATI-2341. The loss of GRK3- or PKC-mediated phosphorylation of Ser-346/7 impaired the recruitment of -arrestin to CXCR4. We also found that a pseudo-substrate peptide inhibitor for PKC effectively inhibited CXCR4 phosphorylation and signaling, most likely by functioning as a nonspecific CXCR4 antagonist. Together, these studies demonstrate the role Ser-346/7 plays in arrestin recruitment and initiation of receptor desensitization and provide insight into the dysregulation of CXCR4 observed in patients with various forms of WHIM syndrome.
G蛋白偶联受体(GPCRs)的磷酸化是细胞信号传导和受体功能调节的关键事件。此前,我们使用串联质谱法在趋化因子受体CXCR4的C末端远端尾部鉴定出两个磷酸化位点,但无法确定具体哪些残基被磷酸化。在此,我们证明,在用激动剂CXCL12以及CXCR4肽模拟物ATI-2341刺激后,CXCR4的丝氨酸(Ser)346和/或347(Ser-346/7)会发生磷酸化。ATI-2341是一种偏向G异源三聚体的CXCR4激动剂,与CXCL12相比,它能诱导Ser-346/7发生更强有力的磷酸化。敲低G蛋白偶联受体激酶(GRK)2、GRK3或GRK6可降低CXCL12诱导的Ser-346/7磷酸化,其中敲低GRK3的效果最为显著,而抑制传统蛋白激酶C(PKC)亚型,尤其是PKC,可降低CXCL12或ATI-2341诱导的Ser-346/7磷酸化。GRK3或PKC介导的Ser-346/7磷酸化缺失会损害β-抑制蛋白向CXCR4的募集。我们还发现,一种PKC的假底物肽抑制剂可有效抑制CXCR4的磷酸化和信号传导,最有可能是通过作为一种非特异性CXCR4拮抗剂发挥作用。总之,这些研究证明了Ser-346/7在抑制蛋白募集和受体脱敏起始过程中所起的作用,并为深入了解在各种形式的WHIM综合征患者中观察到的CXCR4失调现象提供了思路。